1. Home
  2. NAAS vs BGLC Comparison

NAAS vs BGLC Comparison

Compare NAAS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NaaS Technology Inc.

NAAS

NaaS Technology Inc.

HOLD

Current Price

$3.50

Market Cap

9.0M

ML Signal

HOLD

Logo BioNexus Gene Lab Corp Common stock

BGLC

BioNexus Gene Lab Corp Common stock

HOLD

Current Price

$4.24

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAAS
BGLC
Founded
2019
2017
Country
China
Malaysia
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0M
10.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
NAAS
BGLC
Price
$3.50
$4.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.6K
311.3K
Earning Date
03-31-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,817,052.00
$9,465,006.00
Revenue This Year
$378.49
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.21
52 Week Low
$1.96
$2.01
52 Week High
$40.32
$15.60

Technical Indicators

Market Signals
Indicator
NAAS
BGLC
Relative Strength Index (RSI) 49.26 41.85
Support Level $3.31 $4.00
Resistance Level $3.89 $4.31
Average True Range (ATR) 0.26 0.26
MACD -0.01 0.00
Stochastic Oscillator 49.82 33.47

Price Performance

Historical Comparison
NAAS
BGLC

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: